Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be an internal maintenance update and does not affect study details.
    Difference
    0.1%
    Check dated 2026-03-18T18:03:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page header now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T16:57:11.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new site revision label Revision: v3.4.2 was added and an older funding notice was removed. There are no changes to core trial data, eligibility criteria, endpoints, or listed locations; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:46:45.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding, informing users that information may not be up to date and transactions may not be processed, with links to cc.nih.gov and opm.gov. The page revision is updated to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:33:20.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Show glossary has been added; UI labels have been standardized, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page revision is now 'Revision: v3.4.0'. These changes replace the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:53:55.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a minor system revision and does not alter the study details or visible page content.
    Difference
    0.1%
    Check dated 2026-01-14T02:50:13.000Z thumbnail image

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.